Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • May 2002 | Volume 15 - Issue 5
    By Jeff Hall, Editor
    3,617 reads | 0 comments | 09/03/08
    Older ankle implants, initially used in the late ‘70s and early ‘80s, were failures. They either popped out, wore out or subsided into the bone. One podiatric surgeon recalls removing at least one failed ankle implant a week during his residency. Lately, however, there has been a resurgence of interest in ankle implants, although a palpable amount of trepidation and skepticism remains. While only a handful of podiatric surgeons in the United States have used the newer implants (the Agility Ankle and the Beuchel-Pappas device), the majority believe they are more biocompatible. They are rep... continue reading
    
According to Dr. Barrett (shown at right), more than 500,000 EPF procedures have been performed since the procedure received FDA approval in 1992.
    By Stephen L. Barrett, DPM
    43,942 reads | 0 comments | 09/03/08
    Prior to the development of the first endoscopic foot surgery, there was a strong desire not only to find a better, less invasive method to treat recalcitrant mechanical plantar fasciitis surgically but also to develop a more universally consistent surgical approach to what has been labeled an “endemic problem.” Indeed, the standard of care regarding the surgical management of the heel pain has radically changed since the introduction of the endoscopic plantar fasciotomy (EPF). In 1990, there was an almost universal perception within the podiatric community that the spur was the primary c... continue reading

    3,787 reads | 0 comments | 09/03/08
    Are you trying to get a more accurate handle on a patient’s diabetic neuropathy? If so, you may want to check out the SmartPen dual filament sensor from Koven Technology. It says the SmartPen combines a sterile sharp tip sensor and a replaceable, calibrated, retractable Semmes-Weinstein monofilament. According to Koven, the sterile sensor enables you to test for sharp sensations in areas near diabetic foot ulcers. Using the 10gm monofilament helps you assess diabetic neuropathy assessment with touch-pressure sensation and is calibrated for 100 uses, according to the company. Koven adds tha... continue reading